Skip to main content
Canna~Fangled Abstracts

Protocol for a pragmatic trial of Cannabidiol (CBD) to improve chronic pain symptoms among United States Veterans

By June 29, 2024July 2nd, 2024No Comments

Randomized Controlled Trial
. 2024 Jun 29;24(1):250.

doi: 10.1186/s12906-024-04558-3.

Rachel S Bergmans 1 2, Riley Wegryn-Jones 1 2, Catherine Klida 1 2, Vivian Kurtz 1 2, Laura Thomas 2, David A Williams 1 2, Daniel J Clauw 1 2 3, Kelley M Kidwell 4, Amy S B Bohnert 2 5, Kevin F Boehnke 6 7 8
Affiliations 

Abstract

Background: Chronic pain affects over 100 million Americans, with a disproportionately high number being Veterans. Chronic pain is often difficult to treat and responds variably to medications, with many providing minimal relief or having adverse side effects that preclude use. Cannabidiol (CBD) has emerged as a potential treatment for chronic pain, yet research in this area remains limited, with few studies examining CBD’s analgesic potential. Because Veterans have a high need for improved pain care, we designed a clinical trial to investigate CBD’s effectiveness in managing chronic pain symptoms among Veterans. We aim to determine whether CBD oral solution compared to placebo study medication is associated with greater improvement in the Patient Global Impression of Change (PGIC).

Methods: We designed a randomized, double-blind, placebo-controlled, pragmatic clinical trial with 468 participants. Participants will be randomly assigned in a 1:1 ratio to receive either placebo or a CBD oral solution over a 4-week period. The trial is remote via a smartphone app and by shipping study materials, including study medication, to participants. We will compare the difference in PGIC between the CBD and placebo group after four weeks and impacts on secondary outcomes (e.g., pain severity, pain interference, anxiety, suicide ideation, and sleep disturbance).

Discussion: Once complete, this trial will be among the largest to date investigating the efficacy of CBD for chronic pain. Findings from this clinical trial will contribute to a greater knowledge of CBD’s analgesic potential and guide further research. Given the relative availability of CBD, our findings will help elucidate the potential of an accessible option for helping to manage chronic pain among Veterans.

Trial registration: This protocol is registered at clinicaltrials.gov under study number NCT06213233.

Keywords: Analgesic, Cannabinoids, Cannabis, Clinical Trial, Community-engaged research, Marijuana, Pain, Randomized Controlled Trial, Veteran health

PubMed Disclaimer

References

    1. Institute of Medicine: Relieving Pain in America: a blueprint for transforming Prevention, Care, Education, and Research. In. Washington, DC: National Academies; 2011.
    1. Nahin RL, Feinberg T, Kapos FP, Terman GW. Estimated Rates of Incident and Persistent Chronic Pain among US adults, 2019–2020. JAMA Netw Open. 2023;6(5):e2313563. – PMC – DOI – PubMed
    1. Enkema MC, Hasin DS, Browne KC, Stohl M, Shmulewitz D, Fink DS, Olfson M, Martins SS, Bohnert KM, Sherman SE, et al. Pain, cannabis use, and physical and mental health indicators among veterans and nonveterans: results from the national epidemiologic survey on Alcohol and related Conditions-III. Pain. 2022;163(2):267–73. – PMC – DOI – PubMed
    1. Qureshi AR, Patel M, Neumark S, Wang L, Couban RJ, Sadeghirad B, Bengizi A, Busse JW. Prevalence of chronic non-cancer pain among military veterans: a systematic review and meta-analysis of observational studies. BMJ Mil Health 2023.
    1. Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547–55. – DOI – PubMed

Publication types

MeSH terms

Substanes

Associated data

Leave a Reply